VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Firm”), a Odor AI firm digitizing scent into machine-readable knowledge for synthetic intelligence purposes, at the moment highlighted a latest report revealed by VASRO GmbH (“VASRO”), discussing the growth of the Firm’s AI Nostril platform into emergency division operations and the continued development of its Odor ID knowledge throughout various real-world environments.

Within the report, VASRO critiques Ainos’ just lately introduced analysis program at one in all Asia’s main educational medical facilities, the place AI Nostril is being deployed inside a stay emergency division atmosphere to judge environmental scent evaluation for emergency division overcrowding early warning and respiratory an infection threat evaluation. This system is designed to generate greater than 2,500 hours of emergency-department environmental knowledge.

In line with the report, the initiative expands AI Nostril past semiconductor manufacturing, industrial environments, and robotics into a brand new healthcare infrastructure software. VASRO notes that the deployment broadens the vary of environments by which the platform is being evaluated whereas producing real-world scent knowledge that contribute to the continued growth of Ainos’ Odor Language Mannequin (“SLM”).

The report additional highlights similarities between semiconductor manufacturing services and hospital emergency departments as extremely dynamic environments the place early detection of fixing environmental circumstances might present operational worth.

VASRO highlighted the worth of evaluating the expertise inside a stay emergency division atmosphere, offering a further real-world supply of scent knowledge whereas broadening the vary of environments by which the Firm’s Odor AI platform is being evaluated.

“We consider the worth of Odor AI, powered by AI Nostril, comes from its means to function throughout a rising vary of real-world environments,” stated Eddy Tsai, Chairman, President and Chief Govt Officer of Ainos. “As we proceed increasing AI Nostril throughout industrial, healthcare infrastructure, and different environments, we’re additionally increasing the Odor ID knowledge that helps construct Odor AI as a brand new layer of machine notion.”

The complete VASRO report is accessible right here: https://vasro.de/wp-content/uploads/2026/06/VASRO-GmbH_Update_Report_Ainos_Inc_06042026_EN.pdf

About AI Nostril

AI Nostril digitizes scent into Odor ID, an AI-driven type of scent intelligence. The complete-stack digital nostril platform integrates high-precision MEMS sensor arrays with proprietary AI algorithms designed to assist ppb-level scent detection sensitivity, topic to software circumstances and deployment configurations. Odor ID converts analog scent alerts into structured, actionable knowledge, whereas the proprietary Odor Language Mannequin (SLM) is designed to be taught, classify, and contextualize advanced scent patterns over time.

Constructed upon greater than a decade of amassed scent knowledge and deep medtech experience, AI Nostril is designed to assist steady monitoring, predictive evaluation, and real-time alerts throughout industrial and manufacturing environments. AI Nostril is obtainable underneath a SmellTech-as-a-Service structure, supposed to assist ongoing entry to scent intelligence, analytics, and AI-driven insights by means of subscription-based deployment fashions.

About Ainos, Inc.

Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech firm pioneering smelltech and immune therapeutics. Its AI Nostril platform and odor language mannequin (SLM) digitize scent into Odor ID, a machine-readable knowledge format, powering clever sensing throughout robotics, sensible factories, and healthcare. The corporate additionally develops VELDONA^®, a low-dose oral interferon concentrating on uncommon, autoimmune, and infectious illnesses. Ainos, a fusion of “AI” and “Nostril,” is redefining machine notion for the sensory age. To be taught extra, go to https://www.ainos.com. Observe Ainos on X, previously often known as Twitter, (@AinosInc) and LinkedIn to remain up-to-date. Go to media room https://ainos.suite.accessnewswire.com.

Ahead-Wanting Statements

Sure statements on this press launch are forward-looking statements inside the which means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Alternate Act of 1934, as amended. All statements apart from statements of historic reality are forward-looking statements. Ahead-looking statements are based mostly on administration’s present assumptions and expectations of future occasions and tendencies, which have an effect on or might have an effect on the Firm’s enterprise, technique, operations or monetary efficiency, and precise outcomes and different occasions might differ materially from these expressed or implied in such statements on account of quite a few dangers and uncertainties. Ahead-looking statements are inherently topic to dangers and uncertainties, a few of which can’t be predicted or quantified. There are a selection of necessary elements that might trigger precise outcomes, developments, enterprise choices or different occasions to vary materially from these contemplated by the forward-looking statements on this press launch. These elements embrace, amongst different issues, our expectation that we are going to incur web losses for the foreseeable future; our means to develop into worthwhile; our means to lift extra capital to proceed our product growth; our means to precisely predict our future working outcomes; our means to advance our present or future product candidates by means of scientific trials, receive advertising and marketing approval and in the end commercialize any product candidates we develop; the power to acquire and preserve regulatory approval of our product candidates; delays in finishing the event and commercialization of our present and future product candidates; creating and commercializing extra merchandise, together with diagnostic testing gadgets; our means to compete within the market; compliance with relevant legal guidelines, laws and tariffs, and elements described within the Threat Components part of our public filings with the Securities and Alternate Fee (SEC). As a result of forward-looking statements are inherently topic to dangers and uncertainties, you shouldn’t depend on these forward-looking statements as predictions of future occasions. These forward-looking statements communicate solely as of the date of this press launch and, besides to the extent required by relevant legislation, the Firm undertakes no obligation to replace or revise these statements, whether or not on account of any new data, future occasions and developments or in any other case.

Contact Data
Investor Relations
[email protected]

SOURCE: Ainos, Inc.